• Medical_Professionals
• Medical_students
• Nurses

Dear Colleagues,

It is our pleasure to invite you to participate in The 5th International Conference on Prehypertension, Hypertension and Cardio Metabolic Syndrome, which will take place in Venice, Italy from 22-25 February, 2018.

Prehypertension is a part of the continuum from normotension to hypertension it is a part of a dynamic process of stiffening and aging of the arteries and of the heart with its consequences. Patients in the prehypertensive range will become finally hypertensive. Diseased arteries will not only participate in propagation of end organ damage but will enhance the progression of additional damage in the arteries and the heart. Understanding the risk of borderline conditions in the metabolic syndrome will enable us to understand the nature of end organ damage and will create a possibility of better prevention of this continuous process.

Prehypertension is usually associated with other components of the metabolic syndrome i.e. obesity, diabetes, glucose intolerance and dyslipidemia. This association is due to common mechanistic pathways and has implications on cardiovascular complications. Diet and exercise with or without drug therapy benefit all components of the metabolic syndrome. Antihypertensive medications may lead to deterioration in glucose tolerance while glucose lowering agents may affect blood pressure. Thus, any discussion about the approach to prehypertension must be done in context to the whole cardio metabolic risk.

The association of multiple CV risk factors enhances rate of progression of end organ damage and affects morbidity and mortality. The presence of multiple risk factors changes the prognosis of the patients and should affect our therapeutic approach- an area with insufficient information and guidelines.

Systolic blood pressure (BP) of less than 140 mm Hg and diastolic BP of less than 90 mm Hg were for years considered as normal. Mounting evidence suggest that BP in the high reference range is associated with an increased risk of cardiovascular disease. The ESH report of 2006 defined it as “high normal” and the seventh report of the Join National Committee on the Prevention, Detection, Evaluation and Treatment of High Blood Pressure defined a new BP category “Prehypertension” for systolic and diastolic BP: 120 to 139 mm Hg and 85 to 89 mm Hg, respectively. This new category is a continuum to hypertension and is a risk factor for cardiovascular disease.

In most developing countries and in the urban areas of many countries, one in five to one in three adults fall in the category of prehypertension. Recommendation and guidelines in the field have substantial public health importance and enormous economic consequences.

The Conference will aim to deal with all aspects related to early diagnosis, including innovative technologies and treatments and will bring together professionals from the fields of Hypertension, Nephrology, Endocrinology, Internal Medicine, Cardiology and more.

We hope that you will join us for what promises to be a stimulating professional and educational event and look forward to welcoming you to Venice.

Yours sincerely,

Reuven Zimlichman

Giuseppe Ambrosio

ITALY

Cesare Cuspidi

ITALY

Guido Grassi

ITALY

Salvatore Novo

ITALY

Paolo Palatini

ITALY

Achille C. Pessina

ITALY

Manfredi Rizzo

ITALY

Damiano Rizzoni

ITALY

Gian Paolo Rossi

ITALY

EUR

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

Paragon Group is the official travel agent for Prehypertension 2018. All reservations should be made directly via Paragon Group.

Rates are per room and per night, including taxes & buffet breakfast. Not including city taxes currently € 5 per person per night to be paid directly to the hotel.

Submission Info

Abstract submission deadline 2017-11-20

Participants who would like to present their work must submit an abstract in English for consideration by the International Scientific Abstract Review Committee. A maximum of 3 abstracts, per participant, may be submitted. The committee will be responsible for acceptance as an oral or poster presentation or rejection for each submitted abstract.

Only abstracts of authors who have paid their registration fees will be scheduled and included in the Congress materials.

Rules for Submission:

An author from each abstract is expected to attend the congress and present the poster or oral presentation.

All abstracts must be submitted and presented in clear English with accurate grammar and spelling of a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor, prior to submission.

Only abstracts of authors’ who have paid their registration fees by November 20, 2017 will be scheduled for presentation.

Guidelines for Submission:

Before you begin, please prepare the following information:

Presenting author’s contact details: 

Email address

Full postal address

Daytime and evening phone number

Presentation type – please choose from one of the following:

Poster presentation

Oral presentation

Author and co-authors’ details: 

Full first and family name(s)

Affiliation details: department, institution / hospital, city, state (if relevant), country

Abstract title– limited to 20 words in UPPER CASE

Abstract text– limited to 250 words (Please Note: Word count is affected when graphs/tables/images are added)

Abstract topic– abstracts must be allocated to a specific topic for the Scientific Program. Please choose from the list of topics.

Tables– A maximum of 3 tables of up to 10 rows x 10 columns can be included per abstract

Graphs and images– It is important to note that each image included in the abstract is worth 30 words. A maximum of 3 images can be included per abstract. The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload graphs in JPG, GIF or PNG format.

Draft abstracts– The submission form at the link above allows you to store your abstract as a draft in order to make changes. Please note that abstracts must be SUBMITTED before the deadline in order to be sent to review for inclusion in the Scientific Program

Take this unique opportunity to join Prehypertension 2018 Conference and to effectively reach hundreds of the world’s leading international medical professionals.

A full range of sponsorship options has been created to allow each company the opportunity to showcase their organisation as it best suits their needs and budget and to have a full access to all networking benefits.

View the Industry Prospectus

For more information please contact:

Liat Halevy

Project Manager – Industry Liaison 

Mobile: +972-54-4905966

Email: secretariat@prehypertension.org

Liat Halevy , Secretariat , Paragon Group

Phone: +41-22-533-0948

Email: secretariat@prehypertension.org